PhaseBio Pharmaceuticals Inc
F:2K4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PhaseBio Pharmaceuticals Inc
F:2K4
|
US |
|
I
|
Integrated System Credit Consulting Fintech SpA
MIL:ISC
|
IT |
|
T
|
Thurgauer Kantonalbank
F:TK2A
|
CH |
|
Hanna Capital Corp
XTSX:HCC
|
CA |
|
Route 109 Resources Inc
XTSX:RTE
|
CA |
|
Yuvraaj Hygiene Products Ltd
BSE:531663
|
IN |
|
D
|
Devo Energy SA
WSE:DEV
|
PL |
Dividends
Dividend Yield
PhaseBio Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
PhaseBio Pharmaceuticals Inc
2K4 have decreased by 0%.
Payout Ratio
PhaseBio Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 2K4 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2K4 Price
PhaseBio Pharmaceuticals Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -98% |
| Market Capitalization | 49.9 EUR |
| Shares Outstanding | 49 858 100 |
| Percentage of Shares Shorted |
N/A
|
